“Psychosis and Schizophrenia: Update on the latest treatments in Europe and the United States” presented by Sir Robin MacGregor Murray, MD., Professor of Psychiatric Research at the Institute of Psychiatry, King’s College London.
When: Tuesday, May 17, 2016, 6:00-7:30 p.m.
Where: El Camino Hospital, 2500 Grant Road Mountain View 94040, New Main Hospital, Conference rooms E, F &G
Registration required due to limited room capacity: Lauren_Olaiz@elcaminohospital.org
El Camino Hospital, Bay Area Hearing Voices Network and South Bay Project Resource Invite You to a Special Event:
Professor Murray is part of The Psychosis Research Group at the Institute of Psychiatry, one of the largest outside the United States. Professor Murray is ranked as one of the most influential researchers in psychiatry and 3rd in schizophrenia research.
Description: European psychiatrists differ from their American counterparts in both the way they conceptualize schizophrenia and in the way they treat it. It is common to read articles by US neuroscientists which begin “Schizophrenia is a brain disease under genetic influence which causes debilitating symptoms and progresses to a chronic outcome. “ In contrast, most European experts regard schizophrenia as a clinical syndrome which lies at the extreme end of a continuum of psychotic symptoms that that stretches into the general population. It is easier to do epidemiological research in Europe than in the USA, and European researchers have demonstrated that a range of environmental factors increase the risk of schizophrenia e.g. perinatal hypoxia, childhood adversity, migration, drug use and intrusive life events. This talk will compare both European and American models. Professor Murray will further discuss the out-patient care and treatments for psychosis in Europe. He will share the report from the British Schizophrenia Commission which he chaired. There is no such similar analysis available in USA.
Bio: Dr. Robin Murray is Professor of Psychiatric Research at the Institute of Psychiatry, Kings College and indeed has spent most of his working life there apart from one year at NIMH in the USA. His particular interest is in psychosis, and he and his colleagues have contributed to the understanding that environmental factors such as obstetric events, drug abuse and social adversity dysregulate striatal dopamine and thus increase the risk of psychosis; he is currently most interested in gene-environmental interactions. He is also involved in testing new treatments for psychotic illnesses, and cares for people with psychosis at the Maudsley and Bethlem (formerly Bedlam) Hospitals. He has written over 700 articles, not all of them boring! He is the most frequently cited psychosis researcher outside the USA, has supervised 52 PhDs and 40 of his students have become full professors. He was elected a Fellow of the Royal Society in 2010, the fourth psychiatrist ever to be elected (the first was Freud). In 2011, he received a knighthood from the Queen for his work in psychiatry.
Reading: Dr. Murray’s report from Schizophrenia Commission Click Here
For More Information:
Lauren Olaiz, MPH, Community Liaison Specialist, El Camino Hospital: 650-962-4453 or
Corinne Collins RN, FNP South Bay Project Resource: 650-318-1207 or southbayprojectresource.org